(Stroke. 1997;28:1966-1971.)
© 1997 American Heart Association, Inc.
Articles |
From the Stroke Service, Neurology Service (U.C., K.L.F., N.S., F.S.B., W.J.K., J.P.K.); the Department of Pathology (J.F.S.); the Vascular Laboratory (N.R.M.); and the Neurosurgery Service (C.S.O.), Massachusetts General Hospital, Boston, Mass.
Correspondence to J. Philip Kistler, MD, Director, Stroke Service/Cerebrovascular Section, Vascular Laboratory, Massachusetts General Hospital, Fruit Street, Boston, MA 02114. E-mail Furie{at}helix.mgh.harvard.edu
| Abstract |
|---|
|
|
|---|
Methods We selected patients who underwent carotid endarterectomy (CEA) and had preoperative TCD data available. Eighty-one patients underwent transorbital evaluation, 49 of whom also had transtemporal TCD performed. The endarterectomy specimens were removed en bloc and sectioned, and the minimal residual lumen diameter calculated by computer analysis.
Results For the transorbital approach, the strongest indicators of a residual lumen diameter <1.5 mm were reversed flow in the ipsilateral ophthalmic artery and a >50% peak systolic velocity difference between the carotid siphons (distal ICAs) in patients with unilateral ICA origin stenosis. They were 100% specific and 31% and 26% sensitive, respectively. For the transtemporal approach in patients with a unilateral stenosis, a >35% difference in ipsilateral middle cerebral artery (MCA) peak systolic velocity relative to the contralateral MCA or a >50% difference in contralateral anterior cerebral artery (ACA) peak systolic velocity relative to the ipsilateral ACA were 100% specific for identifying a residual lumen diameter of <1.5 mm. Sensitivities were 32% and 43%, respectively. Irrespective of contralateral stenosis, a >35% difference in ipsilateral MCA peak systolic velocity relative to the ipsilateral posterior cerebral artery had a 100% specificity and a 23% sensitivity for detecting a <1.5 mm minimal residual lumen diameter.
Conclusions Although the TCD sensitivity for detecting a hemodynamically significant stenosis is relatively low, it can be highly specific (up to 100%). We conclude that TCD enhances the specificity of highly sensitive CDUS criteria for detecting a hemodynamically significant ICA stenosis.
Key Words: transcranial Doppler carotid arteries pathology diagnostic imaging
| Introduction |
|---|
|
|
|---|
The aim of this study was to correlate the PSV obtained by TCD with the minimal residual diameter calculated from the intact CEA specimens removed en bloc and to identify TCD criteria that will increase the specificity of CDUS for detecting a hemodynamically significant stenosis at the origin of the ICA (residual lumen diameter of <1.5 mm).
The choice of a <1.5 mm residual lumen diameter as a hemodynamically significant stenotic lesion is based on two factors. First, our previous study described receiver-operating characteristic curve analyses demonstrating that CDUS can be either a highly sensitive or a highly specific test for identifying such a stenotic lesion.13 Second, our preliminary TCD data suggested that when the residual lumen diameter decreased to 1.5 mm, changes in flow in the ophthalmic artery, carotid siphon (distal ICA), and intracranial circulation occur (ie, it is the point at which pressure and flow change across the stenosis occur).
Here we present 100% specific TCD criteria for identifying a hemodynamically significant stenotic lesion at the origin of the ICA with a residual lumen diameter of <1.5 mm.
| Materials and Methods |
|---|
|
|
|---|
![]() |
![]() |
Transcranial Doppler Ultrasonography
TCD was performed in the Vascular Laboratory at the
Massachusetts General Hospital using a Medasonics Transpect
transcranial Doppler machine and a 2 MHz probe. MCA,
ACA, and a PCA PSVs were measured from the transtemporal
window and OA, and carotid siphon (distal ICA) flow velocities were
measured from the transorbital window. When more than one velocity was
recorded for the MCA stem, the highest PSV was used. Our laboratory
identifies arteries and defines normal velocities based on published
criteria.14 15 16 17 18
Pathological Specimens
CEA specimens were removed en bloc without disturbing the
lumen.19 They were promptly placed in formalin and
decalcified in nitric acid and EDTA. It had been shown in a previous
report that the fixation did not appreciably change the residual lumen
diameter of the specimens.20 21 Kodachrome images of each
specimen were taken and the length and width of each measured in
centimeters. Using a razor blade, the specimens were then sectioned
horizontally at 0.2-cm intervals and laid in series so that kodachrome
images of each section could be obtained. The Kodachrome image of the
section with the smallest residual lumen was scanned by a slide
scanner, and the images were stored on floppy diskettes. The lumenal
area of each stored image was measured digitally, and the minimal
residual diameter was calculated from this area measurement using an
Aldus photostyler computer program. The residual lumen diameter
measurements were rounded to the nearest 0.1 mm, such that
0.14 mm was recorded as 0.1 mm and 0.15 mm
recorded as 0.2 mm.
| Results |
|---|
|
|
|---|
The calculated residual lumen diameter of the 81 endarterectomy specimens included in this study ranged from 0.21 to 2.72 mm, with a mean value of 1.02 mm.
Transorbital (OA/Carotid Siphon) TCD
The OA and the carotid siphon both were evaluated using the
transorbital approach. The OA signal was analyzed for direction
and velocity of flow. The ipsilateral siphon PSV was compared with the
contralateral siphon and expressed as percent difference.
Flow Direction in the OA and Side-to-Side PSV Correlations
OA recordings of the 81 patients were analyzed for
the flow direction, PSV, and a comparison of the PSV of the
stenotic side to that of the contralateral side. Twenty
patients had an ipsilateral reversed OA flow direction (sensitivity
31% and specificity 100%) (Table 1A
).
OA PSV<20 cm/s was 100% specific (sensitivity 9%). A PSV difference
of >50% (ipsilateral OA <contralateral OA) in patients with normal
flow direction indicated a residual lumen diameter of <1.5 mm,
with a specificity of 87% and a sensitivity of 17%. We observed
"hump-like" spectral configuration in the OA pulse wave in
patients with a <1.5 mm residual lumen, but this finding was
found to be insensitive and was not 100% specific.
|
Unilateral and Side-to-Side Carotid Siphon PSV Comparisons
In the 22 patients with available data, ipsilateral siphon PSV
ranged between 25 and 111 cm/s compared with the contralateral PSVs of
41 to 164 cm/s. A >50% PSV difference between ICA
(contralateral>ipsilateral) predicted a residual lumen diameter of
<1.5 mm with 100% specificity and a sensitivity of 26% (Table 1B
).
Transtemporal TCD
Transtemporal TCD allowed comparison of percent
difference in PSVs between the ipsilateral and contralateral MCAs, the
ipsilateral MCA and PCA, and the ipsilateral and contralateral
ACAs.
Side-to-Side MCA PSV Comparisons
In the 45 patients with available data, an MCA PSV <50 cm/s on
the ipsilateral side only had a specificity of 71% and a sensitivity
of 8% for predicting a residual lumen diameter of <1.5 mm. In
the 34 patients with bilateral MCA insonation, PSV on the ipsilateral
side ranged from 41 to 128 cm/s and on the contralateral side ranged
from 49 to 155 cm/s. A >35% PSV difference between MCAs
(contralateral >ipsilateral) predicted a residual lumen diameter of
<1.5 mm with 100% specificity and a sensitivity of 32% (Table 2A
). The PI of either the ipsilateral MCA
or a comparison of ipsilateral/contralateral PIs was not found
to be either highly specific or sensitive in predicting a residual
lumen of <1.5 mm.
|
Ipsilateral MCA/PCA PSV Comparisons
In 36 patients with available data, MCA PSVs ranged from 41 to 128
cm/s and PCA PSVs ranged from 36 to 231 cm/s. A >35% PSV difference
in ispilateral MCA<PCA predicted a residual lumen diameter of
<1.5 mm with 100% specificity and a sensitivity of 23% (Table 2B
).
ACA Flow Direction and Side-to-Side PSV Comparison
Of 30 patients with ipsilateral ACA recordings, 10 had
reversal of flow (sensitivity 30% and specificity 83%) (Table 2C
).
One of the 10 patients with a reversal of flow in the ipsilateral ACA
had a residual lumen size >1.5 mm (ie, 1.59 mm).
In the 19 patients with available data, the ipsilateral ACA PSVs ranged
from 27 to 83 cm/s, and the contralateral PSVs ranged from 45 to 164
cm/s. A >50% PSV difference between contralateral and ipsilateral
ACAs predicted a residual lumen diameter of <1.5 mm with a
specificity of 100% and a sensitivity of 43% (Table 2D
).
Combined 100% Specific TCD Criteria
Criteria with 100% specificity for identifying a <1.5-mm
residual lumen diameter are summarized in Table 3
. By combining the five most secure of
the 100% specific criteria (ipsilateral OA reversal, >50% PSV
difference between the carotid siphons, >35% PSV difference between
MCAs, >35% PSV difference between ipsilateral PCA and MCA, and >50%
PSV difference between ACAs) so that if any one was present, the
overall sensitivity of TCD increases to 49% for diagnosing a residual
lumen of <1.5 mm (Table 4A
).
Although an OA PSV <20 cm/s was 100% specific, due to the limited
number of observations (n=4), it was not included.
|
|
If patients met any of the 100% specific CDUS criteria (a PSV of >440
cm/s, end-diastolic flow velocity of >155 cm/s, or a
carotid index of >10) derived from our previous study,13
or if patients met any of the 100% specific TCD criteria derived from
this study, a residual lumen diameter of <1.5 mm could be
predicted with a sensitivity of 89% (Table 4B
).
Of the 49 patients who underwent both CDUS and TCD, 29 patients met the 100% specific CDUS criteria developed in our previous study for a residual lumen diameter <1.5 mm.13 Excluding these patients, and the 1 patient who met neither the highly or moderately specific CDUS criteria, 19 remained who met the highly sensitive (96%) but moderately specific (61%) CDUS criteria for predicting this lesion. Thirteen of these 19 patients actually had a minimal residual lumen diameter <1.5 mm. Ten of these13 patients met one of the five 100% specific TCD criteria. Thus, in these patients, the addition of TCD enhanced the highly sensitive CDUS criteria, increasing the overall specificity to 100%.
| Discussion |
|---|
|
|
|---|
Individually, each of our five100% specific TCD criteria had
relatively low sensitivity; however, if all five criteria are looked
for in a given patient but only one is found, the 100% specificity is
preserved and the combined sensitivity increases to 49% (Table 4A
).
These five 100% specific TCD criteria are particularly useful when one
of the three 100% CDUS criteria has not been met, thereby leaving in
doubt the severity and hemodynamic significance of the
stenotic lesion at the origin of the ICA. Combining the three
100% specific CDUS criteria defined in our previous study with the
five 100% specific criteria in this study raises the sensitivity of
the combined tests to 89% (Table 4B
).13
We chose to analyze PSV rather than mean velocity or end-diastolic velocity for two reasons. First, we were concerned that computer-generated mean velocities are inaccurate. End-diastolic velocities have been difficult to measure because the absolute point of end-diastole is obscured by artifact in many cases. PIs are similarly difficult. In contrast, PSVs are easily measured. PIs require manual or computer-generated values for three variables (PSV, EDV, and mean velocity) with their inevitable and compounded measurement errors. Furthermore, using PI we could not find 100% specific criteria for diagnosing a minimal residual lumen diameter of less than or equal to 1.5 mm. In that regard, our data are consistent with those of Wilterdink et al.22 They established their TCD criteria for diagnosing an angiographically derived percent stenosis using Doppler criteria adopted from Langlois et al.23
Second, we and others have observed that absolute PSVs are affected early in the course of a hemodynamically significant stenotic lesion of the internal carotid origin.24 25 26 27 28 But, absolute PSVs are also affected by age, hematocrit, PCO2, cardiac output, and the degree of activation of brain tissue supplied by the artery being insonated.29 30 31 32 33 For these reasons, the percent difference in PSV was used instead of absolute values. PSV generally fell within reported normal ranges.17 18 Six patients had MCA PSVs that fell above the normal range (120 cm/s). Although not systematically reviewed for this paper, all of the patients had preoperative intracranial MRA or conventional angiography to identify those with intracranial stenoses. We were able to review the angiographic findings in all six cases with elevated MCA PSVs and found no evidence of intracranial stenoses. Contralateral ACA or ipsilateral PCA PSV above the reported normal range (110 and 80 cm/s, respectively) may be an indication of collateral flow enhancement due to a hemodynamically significant carotid lesion or, less likely, due to the infrequent occurrence of an intrinsic stenotic lesion in the ACA or PCA.17 PSVs lower than normal in the ipsilateral MCA (<40 cm/s) suggest the presence of a more proximal hemodynamically significant obstructive lesion. In our view, MRA and computerized tomography angiography should be used as adjuncts in confirming the absence of intracranial carotid or proximal middle cerebral artery lesions before endarterectomy.
There are two compelling reasons to identify the TCD criteria that correlate with a hemodynamically significant stenotic lesion at the origin of the ICA. First, the small but definite risk of conventional angiography when measuring percent stenosis has prompted us and others to avoid it in the evaluation of patients with symptomatic and asymptomatic carotid stenoses.10 11 12 We rely instead on CDUS, TCD, and MRA. But, each of these directly or indirectly assesses the actual residual lumen diameter rather than percent stenosis. Thus, it becomes important to correlate the TCD findings of a hemodynamically significant carotid stenosis in terms of residual lumen diameter just as we have done with our CDUS criteria.13
Second, the natural history studies of asymptomatic carotid
stenosis7 8 9 and the symptomatic
endarterectomy trials1 2 all suggest
that the rate of stroke increases with increasing degrees of
stenosis, particularly when the stenotic lesion
measures 70% or greater using the NASCET angiographic criteria. In
addition, NASCET was only able to demonstrate efficacy for carotid
endarterectomy in preventing stroke when the degree
of stenosis was 70% or greater.1 If one assumes
that a lumen diameter of 5 to 6 mm is normal for a distal ICA,
then a 1.5 mm residual lumen diameter corresponds to a 70% to
75% stenosis by the NASCET criteria. Our data suggest that
this is the point at which a pressure drop across the stenosis
occurs in most patients, ie, the point at which the stenotic
lesion at the origin of the ICA becomes hemodynamically
significant. When this occurs and flow is reduced distal to the ICA
stenosis, collateral flow through the OA or circle of Willis is
called into play as it is in carotid occlusion.32 33 34 If
collateral flow is not adequate, low-flow infarcts or transient
ischemic attacks develop, as suggested by Ringelstein et
al33 35 and others.36 37 If collateral flow
is adequate, patients should remain free of low-flow
symptoms.36 But the reduced flow in the ICA may portend
thrombus formation at the ICA stenotic site that either
occludes it and/or embolizes distally to produce symptoms. We
suggest that this is why the natural history studies all show a
substantial increase in stroke risk in the asymptomatic
patient at 70% or greater stenosis and NASCET could only prove
efficacy of surgery at
70% stenosis.1 7 8 9 The
combined CDUS and TCD data presented here and in our previous
study outline highly sensitive and 100% specific criteria for
documenting such a lesion.13
We conclude that TCD is a reliable noninvasive test for predicting the presence of a hemodynamically significant extracranial ICA stenosis. If our selected TCD criteria were used, the specificity of noninvasive CDUS could be enhanced.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received January 10, 1997; revision received July 11, 1997; accepted July 21, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. N. Popa, M. P. Spencer, C. L. Lion, and R. A. Felberg Power M-Mode Doppler and Single-Gate Spectral Analysis Using a 2-MHz Pulsed-Wave Doppler Transducer to Directly Detect Cervical Internal Carotid Artery Stenosis: Use of the Continuity Principle: Report of a Novel Technique Stroke, June 1, 2007; 38(6): 1780 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kistler Carotid Artery Stenosis Circulation, May 2, 2006; 113(17): e740 - e741. [Full Text] [PDF] |
||||
![]() |
M. Kamouchi, K. Kishikawa, Y. Okada, T. Inoue, S. Ibayashi, and M. Iida Reappraisal of Flow Velocity Ratio in Common Carotid Artery to Predict Hemodynamic Change in Carotid Stenosis AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kamouchi, K. Kishikawa, Y. Okada, T. Inoue, S. Ibayashi, and M. Iida Poststenotic Flow and Intracranial Hemodynamics in Patients with Carotid Stenosis: Transoral Carotid Ultrasonography Study AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al. Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Neurology, May 11, 2004; 62(9): 1468 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Romero, M. H. Lev, S.-T. Chan, M. M. Connelly, R. C. Curiel, A. E. Jackson, R. G. Gonzalez, and R. H. Ackerman US of Neurovascular Occlusive Disease: Interpretive Pearls and Pitfalls RadioGraphics, September 1, 2002; 22(5): 1165 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kistler and K. L. Furie Carotid Endarterectomy Revisited N. Engl. J. Med., June 8, 2000; 342(23): 1743 - 1745. [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |